Research in Progress: Alyce S. Adams - Health Policy and the Fight for Equitable Healthcare Outcomes: Why Access Isn’t Enough
Alyce S. Adams, PhD
Professor of Medicine, Stanford's Center for Health Policy & Center for Primary Care and Outcomes Research
Professor of Epidemiology and Population Health in the Stanford School of Medicine
Associate Director for Health Equity and Community Engagement in the Stanford Cancer Institute
Title: Health Policy and the Fight for Equitable Healthcare Outcomes: Why Access Isn’t Enough
Abstract: Using evidence from evaluations of natural experiments, Alyce Adams will discuss the intended and unintended consequences of changes in prescription drug policy at the state and federal level of low income and minority individuals with multiple chronic conditions. We will explore the potential for policy effects to have an immediate and dramatic increase in access to clinically essential treatments. However, she will also discuss where such policies can widen, rather than reduce disparities in treatment. We concluded that increasing access (while critical) is not sufficient to address inequities in treatment use and outcomes among high risk populations. Importantly, new strategies are needed to inform the design of policy interventions that promote access, while simultaneously advancing health equity.
Register in advance for this meeting:
https://stanford.zoom.us/meeting/register/tJcsf-6pqDwtH93u_yfFbEkV_XIbJ2gai0FV
After registering, you will receive a confirmation email containing information about joining the meeting.
Alyce S. Adams
Alyce Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy). She also serves as Associate Chair for Community Outreach and Engagement for Stanford Health Policy, and as Associate Director for Partnership and Community Engagement in the Stanford Cancer Institute. Focusing on pharmaceutical treatments for cancer and diabetes, Dr. Adams' research evaluates health system and policy level interventions to improve access, balance the benefits and harms of treatment, improve patient-valued outcomes, and reduce disparities.